HRP20140185T1 - Peptidi i njihova primjena - Google Patents
Peptidi i njihova primjena Download PDFInfo
- Publication number
- HRP20140185T1 HRP20140185T1 HRP20140185AT HRP20140185T HRP20140185T1 HR P20140185 T1 HRP20140185 T1 HR P20140185T1 HR P20140185A T HRP20140185A T HR P20140185AT HR P20140185 T HRP20140185 T HR P20140185T HR P20140185 T1 HRP20140185 T1 HR P20140185T1
- Authority
- HR
- Croatia
- Prior art keywords
- peptide
- treatment
- fungal infection
- infection according
- sequence
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims 13
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 206010017533 Fungal infection Diseases 0.000 claims 10
- 208000031888 Mycoses Diseases 0.000 claims 10
- 150000001413 amino acids Chemical class 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 208000007163 Dermatomycoses Diseases 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Claims (10)
1. Linearni peptid za primjenu u liječenju gljivične infekcije, pri čemu se taj peptid sastoji od jednog niza od 9 do 15 aminokiselina pri čemu su sve amino kiseline u tom nizu arginin i podliježu 0, 1 ili 2 supstitucije u redoslijedu aminokiselina.
2. Peptid za primjenu u liječenju gljivične infekcije prema zahtjevu 1, naznačen time da se taj peptid sastoji od jednog niza aminokiselina prema sljedećoj formuli (I)
(X)n(I)
gdje je X arginin a n je neki cijeli broj između 9 i 15.
3. Peptid za primjenu u liječenju gljivične infekcije prema zahtjevu 2 u kojem je n neki broj između 11 i 14.
4. Peptid za primjenu u liječenju gljivične infekcije prema zahtjevu 2 u kojem je n neki broj između 12 i 14
5. Peptid za primjenu u liječenju gljivične infekcije prema zahtjevu 4 u kojem je n neki broj između 13 i 14.
6. Peptid za primjenu u liječenju gljivične infekcije prema zahtjevu 2 u kojem je n neki broj između 9 i 13.
7. Peptid za primjenu u liječenju gljivične infekcije prema zahtjevu 6 u kojem je n neki broj između 9 i 11.
8. Peptid za primjenu u liječenju gljivične infekcije prema zahtjevu 2 u kojem je n 13.
9. Peptid za primjenu u liječenju gljivične infekcije prema bilo kojem od prethodnih zahtjeva, pri čemu je infekcija koja se liječi neka dermatofitna infekcija.
10. Peptid za primjenu u liječenju gljivične infekcije prema bilo kojem od zahtjeva 1 do 8, pri čemu je infekcija koja se liječi neka nedermatofitna infekcija.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89928307P | 2007-02-02 | 2007-02-02 | |
| GBGB0702020.9A GB0702020D0 (en) | 2007-02-02 | 2007-02-02 | Peptides and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20140185T1 true HRP20140185T1 (hr) | 2014-05-09 |
Family
ID=37891189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20140185AT HRP20140185T1 (hr) | 2007-02-02 | 2014-02-28 | Peptidi i njihova primjena |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9169290B2 (hr) |
| EP (2) | EP2114988A2 (hr) |
| JP (2) | JP2010517988A (hr) |
| CN (1) | CN101679487B (hr) |
| AU (1) | AU2008211789B2 (hr) |
| CA (1) | CA2706744C (hr) |
| CY (1) | CY1115140T1 (hr) |
| DK (1) | DK2251348T3 (hr) |
| ES (1) | ES2449615T3 (hr) |
| GB (1) | GB0702020D0 (hr) |
| HK (1) | HK1145506A1 (hr) |
| HR (1) | HRP20140185T1 (hr) |
| NZ (1) | NZ578970A (hr) |
| PL (1) | PL2251348T3 (hr) |
| PT (1) | PT2251348E (hr) |
| SI (1) | SI2251348T1 (hr) |
| WO (1) | WO2008093060A2 (hr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0702021D0 (en) | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| WO2009153418A1 (fr) * | 2008-06-16 | 2009-12-23 | Centre National De La Recherche Scientifique (C.N.R.S) | Peptides harp inhibant la croissance tumorale |
| FR2941231B1 (fr) | 2009-01-16 | 2016-04-01 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
| CN102432672A (zh) * | 2011-12-13 | 2012-05-02 | 重庆理工大学 | 一组新型合成抗菌肽及其应用 |
| GB201204457D0 (en) * | 2012-03-14 | 2012-04-25 | Novabiotics Ltd | Polypeptides and their use |
| CN104507309B (zh) | 2012-03-19 | 2017-05-03 | 奇达拉治疗公司 | 用于棘白菌素类化合物的给药方案 |
| US20160250285A1 (en) * | 2013-10-30 | 2016-09-01 | University Of Western Australia | Neuroprotective peptides |
| GB201405891D0 (en) * | 2014-04-02 | 2014-05-14 | Novabiotics Ltd | Modified antimicrobial peptides |
| US10815276B2 (en) | 2014-05-21 | 2020-10-27 | Entrada Therapeutics, Inc. | Cell penetrating peptides and methods of making and using thereof |
| ES2739613T3 (es) | 2014-05-21 | 2020-02-03 | Entrada Therapeutics Inc | Péptidos que penetran en las células y sus métodos de preparación y su uso |
| US10456443B2 (en) | 2014-08-27 | 2019-10-29 | Ohio State Innovation Foundation | Peptidyl calcineurin inhibitors |
| US9675659B2 (en) | 2015-08-21 | 2017-06-13 | Trilogy Therapeutics, Inc. | Methods of treating lung infection with caspofungin |
| CN108883152A (zh) | 2016-01-08 | 2018-11-23 | 奇达拉治疗公司 | 防止和治疗肺孢子虫感染的方法 |
| CN109154603A (zh) | 2016-03-16 | 2019-01-04 | 奇达拉治疗公司 | 用于治疗真菌感染的给药方案 |
| GB201609925D0 (en) * | 2016-06-07 | 2016-07-20 | Novabiotics Ltd | Formulation |
| WO2018191692A1 (en) * | 2017-04-14 | 2018-10-18 | Cidara Therapeutics, Inc. | Methods for treating fungal infections |
| EP3651801A4 (en) | 2017-07-12 | 2021-04-07 | Cidara Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATMENT OF MUSHROOM INFECTION |
| WO2019148194A2 (en) | 2018-01-29 | 2019-08-01 | Ohio State Innovation Foundation | Peptidyl inhibitors of calcineurin-nfat interaction |
| EP3755351A4 (en) | 2018-02-22 | 2021-11-24 | Entrada Therapeutics, Inc. | COMPOSITIONS AND TREATMENT METHODS FOR MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY |
| US11344614B2 (en) * | 2018-09-29 | 2022-05-31 | Emergex Vaccines Holding Ltd. | Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes |
| KR102429281B1 (ko) * | 2020-05-25 | 2022-08-05 | (주)노바셀테크놀로지 | 신규 안구건조증 치료용 약학적 조성물 |
| CN113336824A (zh) * | 2021-04-30 | 2021-09-03 | 重庆理工大学 | 一种多肽在作为pd-1/pd-l1蛋白-蛋白相互作用(ppi)调节剂中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0149254A3 (en) | 1983-12-29 | 1987-01-28 | The Research Foundation Of State University Of New York | Fungicidal polypeptide compositions containing l-histidine |
| US5646120A (en) * | 1990-10-24 | 1997-07-08 | Allelix Biopharmaceuticals, Inc. | Peptide-based inhibitors of HIV replication |
| EP0975370B9 (en) * | 1997-05-21 | 2004-11-03 | The Board Of Trustees Of The Leland Stanford Junior University | Composition and method for enhancing transport across biological membranes |
| US8038984B2 (en) * | 1998-06-20 | 2011-10-18 | Washington University | Membrane-permeant peptide complexes for treatment of sepsis |
| US7049395B2 (en) * | 2000-05-02 | 2006-05-23 | Yale University | Anti-inflammatory compounds and uses thereof |
| US20040142892A1 (en) * | 2001-04-30 | 2004-07-22 | The University Of British Columbia | Autogene nucleic acids encoding a secretable RNA polymerase |
| US7033991B2 (en) * | 2001-07-16 | 2006-04-25 | Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College | Inhibiting furin with polybasic peptides |
| WO2003020213A2 (en) * | 2001-08-30 | 2003-03-13 | Praecis Pharmaceuticals Incorporated | Methods and compositions for treating inflammatory disorders |
| AU2003297657A1 (en) * | 2002-11-29 | 2004-06-23 | Adaptive Therapeutics, Inc. | Antifungal therapeutic agents |
| US7125842B2 (en) * | 2003-04-07 | 2006-10-24 | Canbas Co. Ltd. | Anti-fungal compounds and methods of use |
| US20050203892A1 (en) * | 2004-03-02 | 2005-09-15 | Jonathan Wesley | Dynamically integrating disparate systems and providing secure data sharing |
| ATE479704T1 (de) * | 2004-08-18 | 2010-09-15 | Novabiotics Ltd | Antimikrobielle peptide mit einem arginin- und /oder lysin-haltigen motiv |
| CA2655448C (en) | 2005-12-22 | 2016-09-06 | Novabiotics Limited | Cyclic antimicrobial peptides |
| JP4520477B2 (ja) * | 2006-10-31 | 2010-08-04 | 株式会社マルハニチロ食品 | 抗真菌ペプチドまたはそれを含有するペプチド組成物とその製造方法 |
| GB0702021D0 (en) | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| GB0702022D0 (en) | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
-
2007
- 2007-02-02 GB GBGB0702020.9A patent/GB0702020D0/en not_active Ceased
-
2008
- 2008-01-28 CN CN200880009167.7A patent/CN101679487B/zh active Active
- 2008-01-28 PT PT100093046T patent/PT2251348E/pt unknown
- 2008-01-28 AU AU2008211789A patent/AU2008211789B2/en active Active
- 2008-01-28 EP EP08701955A patent/EP2114988A2/en not_active Withdrawn
- 2008-01-28 WO PCT/GB2008/000283 patent/WO2008093060A2/en active Application Filing
- 2008-01-28 ES ES10009304.6T patent/ES2449615T3/es active Active
- 2008-01-28 US US12/525,523 patent/US9169290B2/en active Active
- 2008-01-28 SI SI200831157T patent/SI2251348T1/sl unknown
- 2008-01-28 DK DK10009304.6T patent/DK2251348T3/en active
- 2008-01-28 PL PL10009304T patent/PL2251348T3/pl unknown
- 2008-01-28 JP JP2009547750A patent/JP2010517988A/ja active Pending
- 2008-01-28 CA CA2706744A patent/CA2706744C/en active Active
- 2008-01-28 NZ NZ578970A patent/NZ578970A/en unknown
- 2008-01-28 EP EP10009304.6A patent/EP2251348B1/en active Active
-
2010
- 2010-12-22 HK HK10112002.9A patent/HK1145506A1/xx unknown
-
2013
- 2013-07-04 JP JP2013141102A patent/JP5882260B2/ja not_active Expired - Fee Related
-
2014
- 2014-02-28 HR HRP20140185AT patent/HRP20140185T1/hr unknown
- 2014-02-28 CY CY20141100165T patent/CY1115140T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100184696A1 (en) | 2010-07-22 |
| CY1115140T1 (el) | 2016-12-14 |
| ES2449615T3 (es) | 2014-03-20 |
| CA2706744A1 (en) | 2008-08-07 |
| CN101679487A (zh) | 2010-03-24 |
| AU2008211789B2 (en) | 2013-11-14 |
| WO2008093060A3 (en) | 2008-10-23 |
| PL2251348T3 (pl) | 2014-05-30 |
| EP2251348A2 (en) | 2010-11-17 |
| JP2010517988A (ja) | 2010-05-27 |
| JP2014012667A (ja) | 2014-01-23 |
| HK1145506A1 (en) | 2011-04-21 |
| NZ578970A (en) | 2012-04-27 |
| SI2251348T1 (sl) | 2014-05-30 |
| JP5882260B2 (ja) | 2016-03-09 |
| CA2706744C (en) | 2017-12-05 |
| WO2008093060A2 (en) | 2008-08-07 |
| EP2114988A2 (en) | 2009-11-11 |
| EP2251348A3 (en) | 2011-03-02 |
| DK2251348T3 (en) | 2014-03-03 |
| US9169290B2 (en) | 2015-10-27 |
| CN101679487B (zh) | 2018-04-03 |
| AU2008211789A1 (en) | 2008-08-07 |
| EP2251348B1 (en) | 2014-01-15 |
| PT2251348E (pt) | 2014-03-06 |
| GB0702020D0 (en) | 2007-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20140185T1 (hr) | Peptidi i njihova primjena | |
| EP3578193A3 (en) | Peptides and their use | |
| PH12014500902A1 (en) | Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same | |
| NZ595037A (en) | Inhibition of biofilm organisms by combination of cysteamine and repetitive peptides | |
| BR112012011332A2 (pt) | agentes direcionados para gadd45beta | |
| EP3428181A3 (en) | Anti-inflammatory peptides and composition comprising the same | |
| NZ600690A (en) | Fkbp-l and uses thereof | |
| MX2014000210A (es) | Peptidos procoagulantes y sus derivados, y usos para estos. | |
| CL2016001405A1 (es) | A peptide mixture | |
| NZ607069A (en) | Modified relaxin polypeptides and their uses | |
| WO2008093058A3 (en) | Peptides and their use | |
| NZ593815A (en) | Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use | |
| MX2017016227A (es) | Peptidos anti-infecciosos de amplio espectro. | |
| AR120721A2 (es) | Péptidos y composiciones para el tratamiento de daño articular | |
| RS54422B1 (en) | APOPTOSIS INHIBITORS AND THEIR USES | |
| JP2010265269A5 (hr) | ||
| HRP20170794T1 (hr) | Izvedeni peptidi faktora viii za upotrebu u liječenju hemofilije a | |
| IN2014DN09963A (hr) | ||
| WO2008084478A3 (en) | Anti-bacterial peptides and methods of treating diseases using same | |
| WO2012153337A3 (en) | Anti-microbial peptides and uses of same | |
| EP3026057A3 (en) | Compositions for prevention and treatment of neurodegenerative diseases | |
| ATE518878T1 (de) | Antimikrobielle peptide | |
| WO2009105780A3 (en) | Mntf peptide compositions and methods of use | |
| MX2019013874A (es) | Peptidos y sus usos como agentes antivirales. | |
| MX2009000800A (es) | Peptidos ciclicos anti-inflamatorios y anti-alergicos. |